President Urges Breaking Down Drug, Device Distinctions, Regulatory Barriers
This article was originally published in The Pink Sheet Daily
Executive Summary
At White House summit on precision medicine, President Obama emphasized the need to break down outmoded regulations, and suggested barriers between drug and device oversight need to be loosened; FDA and NIH announced a number of new competitions and projects.
You may also be interested in...
US FDA’s Precision Medicine Efforts Turn Towards Adverse Events
Next PrecisionFDA challenge aims to detect ‘adverse event anomalies’ including manufacturer-specific patterns and drug-drug interactions.
Califf On Capitol Hill: Rally Friends, Repair Relationships
The new FDA commissioner cautions rare disease advocates about fighting for ineffective treatments and looks to repair communication problems with Senate.
Califf On Capitol Hill: Rally Friends, Repair Relationships
The new FDA commissioner cautions rare disease advocates about fighting for ineffective treatments and looks to repair communication problems with Senate.